HemaSphere
(Jun 2022)
P1509: BONE MARROW TFR2 GENETIC DELETION ABROGATES BLOOD TRANFUSION REQUIREMENT IN THE HBBTH1/TH2 Β-THALASSEMIC MURINE MODEL
- S. M. Di Modica,
- E. Tanzi,
- V. Olivari,
- M. R. Lidonnici,
- M. Pettinato,
- A. Pagani,
- F. Tiboni,
- G. Ferrari,
- L. Silvestri,
- S. Rivella,
- A. Nai
Affiliations
- S. M. Di Modica
- 1 Division of Genetics and Cellular Biology, San Raffaele Scientific Institute
- E. Tanzi
- 1 Division of Genetics and Cellular Biology, San Raffaele Scientific Institute
- V. Olivari
- 1 Division of Genetics and Cellular Biology, San Raffaele Scientific Institute
- M. R. Lidonnici
- 4 San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), San Raffaele Scientific Institute, Milan, Italy
- M. Pettinato
- 1 Division of Genetics and Cellular Biology, San Raffaele Scientific Institute
- A. Pagani
- 1 Division of Genetics and Cellular Biology, San Raffaele Scientific Institute
- F. Tiboni
- 4 San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), San Raffaele Scientific Institute, Milan, Italy
- G. Ferrari
- 4 San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), San Raffaele Scientific Institute, Milan, Italy
- L. Silvestri
- 1 Division of Genetics and Cellular Biology, San Raffaele Scientific Institute
- S. Rivella
- 5 Division of Hematology, Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, United States of America
- A. Nai
- 1 Division of Genetics and Cellular Biology, San Raffaele Scientific Institute
- DOI
-
https://doi.org/10.1097/01.HS9.0000848892.71721.c6
- Journal volume & issue
-
Vol. 6
pp.
1390
– 1391
WeChat QR code